Menicon Co., Ltd. (MNNLF)
OTCMKTS · Delayed Price · Currency is USD
7.10
0.00 (0.00%)
Oct 2, 2025, 9:30 AM EDT
Menicon Market Cap
Menicon has a market cap or net worth of $566.79 million as of October 7, 2025. Its market cap has decreased by -18.44% in one year.
Market Cap
566.79M
Enterprise Value
844.09M
Revenue
842.74M
Ranking
n/a
PE Ratio
16.87
Stock Price
$7.10
Market Cap Chart
Since June 25, 2015, Menicon's market cap has increased from 370.39M to 566.79M, an increase of 53.03%. That is a compound annual growth rate of 4.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 566.79M | -16.11% |
| Dec 30, 2024 | 675.65M | -46.75% |
| Dec 29, 2023 | 1.27B | -20.62% |
| Dec 30, 2022 | 1.60B | -28.38% |
| Dec 30, 2021 | 2.23B | -2.29% |
| Dec 30, 2020 | 2.28B | 48.63% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |